Latest News and Press Releases
Want to stay updated on the latest news?
-
Seasoned dermatology and immunology executive brings more than 25 years of experience advancing and launching innovative therapies, including OPZELURA®, povorcitinib, ILUMYA®, ODOMZO®, REMICADE®, and...
-
Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy
-
Stardust Power Engages 38 North Solutions To Support Federal Government Relations
-
Name change to Kyntra Bio reflects the newly sharpened focus of the Company on novel therapies with potential for outsized impact in oncology and rare diseaseKyntra Bio will begin trading on Nasdaq...
-
WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically...
-
TORONTO & PALO ALTO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- FreshBooks, a platform designed to simplify the financial complexity of running a service based small business, today announced a strategic...
-
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will present at the 44th...
-
Extends Arlington Valley (Arlington) tolling agreement with the current counterparty by 7 years through 2038, increasing the remaining contract life to 13 yearsAdds 35 MW of incremental capacity to...
-
Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
TappAlpha and Tuttle Capital Launch the T² Lift™ Series with TSYX and TDAX